98 related articles for article (PubMed ID: 9554281)
1. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
Walker KB; Xing DK; Sesardic D; Corbel MJ
Dev Biol Stand; 1998; 92():259-67. PubMed ID: 9554281
[TBL] [Abstract][Full Text] [Related]
2. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
4. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
6. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
[TBL] [Abstract][Full Text] [Related]
7. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
Gupta RK; Siber GR
Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
[TBL] [Abstract][Full Text] [Related]
8. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
9. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
10. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
11. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
Xing DK; McLellan K; Corbel MJ; Sesardic D
Biologicals; 1996 Mar; 24(1):57-65. PubMed ID: 8733602
[TBL] [Abstract][Full Text] [Related]
12. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.
Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
Vaccine; 2004 Mar; 22(11-12):1423-32. PubMed ID: 15063565
[TBL] [Abstract][Full Text] [Related]
13. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
Kipper MJ; Wilson JH; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res A; 2006 Mar; 76(4):798-810. PubMed ID: 16345084
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
[TBL] [Abstract][Full Text] [Related]
15. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity.
Faisal SM; Yan W; McDonough SP; Chang YF
Vaccine; 2009 Jan; 27(3):378-87. PubMed ID: 19022317
[TBL] [Abstract][Full Text] [Related]
16. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
17. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
Jung T; Koneberg R; Hungerer KD; Kissel T
Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
[TBL] [Abstract][Full Text] [Related]
18. IL-12 is an effective adjuvant for induction of mucosal immunity.
Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
[TBL] [Abstract][Full Text] [Related]
19. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
[TBL] [Abstract][Full Text] [Related]
20. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
Mohaghegh M; Tafaghodi M
Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
